DOJ Alleges UCLA Med School Discriminated in Admissions
Federal investigators say UCLA's David Geffen School of Medicine used race in admissions in ways that violated civil ...
During recessions, some index funds fare better than others. This intro highlights selection criteria and defensive positioning.
25,743 articlesFederal investigators say UCLA's David Geffen School of Medicine used race in admissions in ways that violated civil ...
As investors eye small-cap medical devices, Inogen's INGN 2026 earnings story matters. This analysis breaks down Q1 r...
A famed market forecaster is signaling a bold by-year-end target for the S&P 500, driven by resilient earnings and a ...
Amentum faces a pivotal Q2 2026 earnings season. This deep dive breaks down backlog, margins, and guidance, with prac...
Dynatrace stock plummeted today after earnings beat but soft guidance signaled a cautious path ahead. This article br...
Florida challenges to the Rooney Rule intensify a national debate over DEI policies in sports. Investors and sponsors...
With winter looming, Ryanair faces higher jet fuel costs. The airline’s CFO says contingency plans are in place as fu...
Investors eye a $100,000 ultra-high-yield portfolio as rates pause and markets prize cash flow. The model promises ro...
As investors parse Nano-X Imaging's Q4 2025 results, this guide breaks down the numbers, the business model, and what...
Barnes Noble clarifies Bookseller’s AI policy, saying it will not ban AI-written titles but will require clear labeli...
Charles Hoskinson pivots back to Cardano as Midnight winds toward a close after a $250 million investment in Wyoming....
Berkshire Hathaway underperforming vs the S&P 500 in 2026, even as Warren Buffett’s top holdings rise. A look at why ...